Nuvation Bio Inc

Sumitovant Biopharma, Inc., based in New York, NY, is dedicated to improving global health by driving innovative treatments in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy. Their diverse pipeline of preclinical and clinical programs aims to address high patient needs through a technology-driven approach. Sumitovant Biopharma, Inc., through its U.S. subsidiary, Sumitomo Pharma America, Inc., embodies a bold promise of combining technology and life-sciences expertise to deliver patient-first solutions faster and more efficiently, ultimately improving patient outcomes worldwide.Generated from the website

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company based in New York City and Waltham, MA. They are dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases. With their lead antibody, DNTH103, they aim to improve the lives of patients by offering less frequent and more convenient self-administered subcutaneous injections through purposeful engineering with extended half-life, improved potency, and high selectivity for the active C1s complement protein that drives disease pathology. Supported by a strong syndicate of experienced life science investors, including 5AM Ventures, Avidity Partners, Fairmount, Fidelity Management Research Company, Tellus BioVentures, Venrock, Wedbush Healthcare Partners, and others, Dianthus Therapeutics is led by a multidisciplinary team of biotech entrepreneurs and scientists. Their team is committed to delivering novel and highly differentiated monoclonal antibodies that target validated and emerging complement targets with improved selectivity and potency over existing therapies. Dianthus Therapeutics is currently seeking visionary, entrepreneurial, and passionate individuals to join their team and make a lasting impact in the lives of patients through novel complement therapeutics.Generated from the website

Hoth Therapeutics is a New York-based pharmaceutical company dedicated to developing innovative and impactful treatments that aim to enhance the quality of life for patients. With a patient-centric approach and a commitment to compassion, Hoth Therapeutics focuses on addressing unmet medical needs in areas such as oncology, neurology, inflammatory dermatology, and medical devices. As a catalyst in early-stage pharmaceutical research and development, Hoth Therapeutics strives to elevate promising drugs from the laboratory to pre-clinical and clinical testing, with the ultimate goal of improving patient care and well-being.Generated from the website